Substance Use Disorders, 1st ed. 2020 From Etiology to Treatment Handbook of Experimental Pharmacology Series, Vol. 258
Coordonnateurs : Nader Michael A., Hurd Yasmin L.
1. Methods for Population Research on Substance Use and Consequences
Mark Wolfson, Kimberly G. Wagoner, Eunyoung Y. Song, Melinda Pankratz, Sunday Azagba
2. Translational Molecular Approaches in Substance Abuse Research
Sasha L. Fulton and Ian Maze
3. Small Molecule Neuropeptide-S and Melanocortin Receptor Ligands As Potential Treatments for Substance Use Disorders
Bruce Blough and Ojas Namjoshi
4. Emerging Insights into Mu Opioid Pharmacology
Gavril W. Pasternak, Steven R. Childers, and Ying-Xian Pan
5. Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors
Lisa R. Gerak, David R. Maguire, and Charles P. France
6. The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research
Matthew L. Banks
7. Clinical Trials for Opioid Use Disorder
Esther Blessing, Sanya Virani, and John Rotrosen
8. Modelling Differential Vulnerability to Substance Use Disorder in Rodents: Neurobiological Mechanisms
Bianca Jupp, Jolyon A. Jones, and Jeffrey W. Dalley
9. Activity-Dependent Epigenetic Remodeling in Cocaine Use Disorder
Alberto J. López, Cody A. Siciliano, and Erin S. Calipari
10. Molecular Mechanisms of Amphetamines
Maarten E. A. Reith and Margaret E. Gnegy
11. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes
Paul S. Regier, Kyle M. Kampman, and Anna Rose Childress12. Molecular Mechanism and Cannabinoid Pharmacology
Lesley D. Schurman, Dai Lu, Debra A. Kendall, Allyn C. Howlett, 3 and Aron H. Lichtman
13. Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents
Suzanne Nielsen, Pamela Sabioni, Linda Gowing, and Bernard Le Foll
14. Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence
Christie D. Fowler, Jill R. Turner, and M. Imad Damaj
15. Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade
Marie N. S. Gendy, Christine Ibrahim, Matthew E. Sloan, and Bernard Le Foll
16. Adolescent Vulnerability to Alcohol Use Disorder: Neurophysiological Mechanisms from Preclinical Studies
Brian A. McCool and Molly M. McGinnis
17. Medication Development for Alcohol Use Disorder: A Focus on Clinical StudiesLorenzo Leggio, Daniel E. Falk, Megan L. Ryan, Joanne Fertig, 3 and Raye Z. Litten
18. Newly Emerging Drugs of Abuse
Kenichi Tamama and Michael J. Lynch
Focuses on each substance used and abused from epidemiology, molecular biology, animal models and human subjects/clinical research reinforcing basic principles of pharmacology throughout
Broadens understanding of the commonalities and differences associated with each drug of abuse
Provides the reader with state-of-the-art, cutting edge research methods
Date de parution : 05-2021
Ouvrage de 502 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 158,24 €
Ajouter au panierDate de parution : 05-2020
Ouvrage de 502 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 158,24 €
Ajouter au panier